Better results for patients on chemotherapy, radiotherapy and gene therapy A personalised test that tells how well chemotherapy,...

TestAVec's hInGeTox saftey assay has been awarded a patent from Japan. Two of TestAVec's key saftey tests, hInGeTox and DiNARep, have now...

TestAVec went to the 30th ESGCT Congress, this year held in the beautiful city of Brussels. Robert, Mike and Saqlain attended the...

TestAVec CSO, Professor Michael Themis, also Head of the Gene Therapy research group at Brunel University London, and his team have...

From all of us at TestAVec, we wish you a wonderful Christmas and new year. We look forward to working with you in 2022.